Rubella medical therapy: Difference between revisions

	Rubella Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Rubella from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Case Studies
Case #1
Rubella medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Rubella medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Rubella medical therapy
CDC on Rubella medical therapy
Rubella medical therapy in the news
Blogs on Rubella medical therapy
Directions to Hospitals Treating Rubella
Risk calculators and risk factors for Rubella medical therapy

Revision as of 16:22, 25 April 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

There is no specific antiviral therapy for rubella infection.

There is no specific antiviral therapy for rubella infection.

@@ Line 7: / Line 7: @@
 ==Treatment==
-Symptoms are usually treated with [[paracetamol]] until the disease has run its course. Treatment of newly born babies is focused on management of the complications. [[Congenital heart defects]] and [[cataract]]s can be corrected by surgery.<ref name="pmid17197734">{{cite journal
+There is no specific antiviral therapy for rubella infection.
-|author=Khandekar R, Sudhan A, Jain BK, Shrivastav K, Sachan R
-|title=Pediatric cataract and surgery outcomes in Central India: a hospital based study.
-|journal=Indian J Med Sci
-|volume=61
-|issue=1
-|pages=15–22
-|year=2007
-|pmid=17197734
-|doi=
-|url=http://www.indianjmedsci.org/article.asp?issn=0019-5359;year=2007;volume=61;issue=1;spage=15;epage=22;aulast=Khandekar
-}}</ref> Management for ocular CRS is similar to that for age-related [[macular degeneration]], including counseling, regular monitoring, and the provision of low vision devices, if required.<ref name="pmid12365660">{{cite journal
-|author=Weisinger HS, Pesudovs K
-|title=Optical complications in congenital rubella syndrome
-|journal=Optometry
-|volume=73
-|issue=7
-|pages=418–24
-|year=2002
-|pmid=12365660
-|doi=
-}}</ref>
 ==References==